This case study showcases how a top global pharmaceutical company leveraged deep, market-specific patient journey insights to sharpen its hypertension strategy across mature and emerging markets.

AI model using head CT imaging predicts in-hospital mortality for patients with gunshot wounds to the head with high discriminative performance.

A 4-year study of cataract surgeons found that access to an unmasked peer benchmarking dashboard, supported by a noncoercive, ...

The expansion study comprises two cohorts of nimacimab monotherapy (400 mg IV and 600 mg IV) compared to placebo administered weekly over 15 weeks (16 doses), with a 12 week follow-up period, to ...

The trend for unvaccinated blood donations raises concerns about patient safety and resource efficiency, emphasizing the need ...

A large portion of the session focused on what the guidelines referred to as the “indeterminate phase” or “grey zone” of CHB, ...

The co-occurrence of a giant Morgagni hernia (MH) and a large hiatal hernia (HH) is exceedingly rare. We describe key operative steps of simultaneous surgical treatment of a large MH and HH, including ...

Introduction Genomic testing allows for the identification of disease-causing genetic variants and may also reveal secondary ...

Patients with up to 20 brain metastases demonstrated significantly improved daily and neurocognitive functioning with ...

Ollin Biosciences announces final data from randomized head-to-head study of OLN324 compared to faricimab in wAMD and diabetic macular edema: Austin, Texas Wednesday, April 1, 202 ...

A phase 1b randomized, head-to-head study suggests that the investigational VEGF/Ang2 bispecific antibody OLN324 may offer ...